Detalhe da pesquisa
1.
Trial of Beremagene Geperpavec (B-VEC) for Dystrophic Epidermolysis Bullosa.
N Engl J Med
; 387(24): 2211-2219, 2022 12 15.
Artigo
Inglês
| MEDLINE | ID: mdl-36516090
2.
Practical considerations relevant to treatment with the gene therapy beremagene geperpavec-svdt for dystrophic epidermolysis bullosa.
J Dermatolog Treat
; 35(1): 2350232, 2024 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-38724041
3.
Pulmonary nontuberculous mycobacterial disease: prospective study of a distinct preexisting syndrome.
Am J Respir Crit Care Med
; 178(10): 1066-74, 2008 Nov 15.
Artigo
Inglês
| MEDLINE | ID: mdl-18703788
4.
Nocardia infection in chronic granulomatous disease.
Clin Infect Dis
; 35(4): 390-4, 2002 Aug 15.
Artigo
Inglês
| MEDLINE | ID: mdl-12145721
5.
Host susceptibility factors in mycobacterial infection. Genetics and body morphotype.
Infect Dis Clin North Am
; 16(1): 163-86, 2002 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-11917812
6.
Reinfection, rather than persistent infection, in patients with chronic granulomatous disease.
J Infect Dis
; 187(5): 845-53, 2003 Mar 01.
Artigo
Inglês
| MEDLINE | ID: mdl-12599059